Indrayani Biotech Limited (BOM:526445)

Indrayani Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	-	42.56	2.88	5.82	30.37	15.03
Short-Term Investments	-	-	-	296.7	96.58	6.77
Cash & Short-Term Investments	42.56	42.56	2.88	302.52	126.94	21.8
Cash Growth	-83.94%	1376.89%	-99.05%	138.31%	482.33%	221.19%
Accounts Receivable	-	585.8	586.9	395.29	299.72	140.99
Other Receivables	-	-	-	245.41	177.15	12.83
Receivables	-	607.68	672.52	709.17	500.53	153.82
Inventory	-	377.84	413.42	423.51	122.14	15.32
Other Current Assets	-	559.12	690.53	14.56	25.62	4.97
Total Current Assets	-	1,587	1,779	1,450	775.23	195.91
Property, Plant & Equipment	-	636.08	600.04	593.77	478.56	259.38
Long-Term Investments	-	2.79	2.48	2.23	2.23	0.01
Goodwill	-	233.47	233.47	233.47	233.47	38.41
Other Intangible Assets	-	-	0.01	-	0.15	-
Long-Term Deferred Tax Assets	-	24.4	2.26	3.32	0.38	-
Other Long-Term Assets	-	50.32	64.04	57.46	69.6	20.3
Total Assets	-	2,534	2,682	2,340	1,560	514.01

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	-	140.58	235.83	373.9	227.38	58.2
Accrued Expenses	-	-	-	55.3	54.82	22.03
Short-Term Debt	-	-	-	398.51	314.31	111.03
Current Portion of Long-Term Debt	-	704.18	716.57	12.16	19.44	-
Current Portion of Leases	-	-	-	7.93	11.25	3.57
Current Income Taxes Payable	-	-	-	6.19	2.01	-
Current Unearned Revenue	-	-	-	0.33	0.12	-
Other Current Liabilities	-	85.05	72.44	16.4	89.77	-
Total Current Liabilities	-	929.82	1,025	870.72	719.1	194.82
Long-Term Debt	-	578.88	654.15	665.97	293.7	67.85
Long-Term Leases	-	-	-	40.67	63.16	5.5
Long-Term Deferred Tax Liabilities	-	4.74	2.76	-	0.14	0.14
Other Long-Term Liabilities	-	-	0.75	-	-	-
Total Liabilities	-	1,513	1,682	1,577	1,076	268.31

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	-	455.36	455.36	455.36	342.27	342.27
Additional Paid-In Capital	-	-	-	126.64	114.01	0.09
Retained Earnings	-	-	-	48.94	-13.36	-100.72
Comprehensive Income & Other	-	273.51	269.73	41.18	15.44	-
Total Common Equity	728.88	728.88	725.1	672.12	458.37	241.63
Minority Interest	-	291.97	274.07	90.54	-67.34	4.06
Shareholders' Equity	1,021	1,021	999.16	762.66	483.53	245.7
Total Liabilities & Equity	-	2,534	2,682	2,340	1,560	514.01

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	1,283	1,283	1,371	1,125	701.86	187.94
Net Cash (Debt)	-1,240	-1,240	-1,368	-822.72	-574.92	-166.15
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-116.46	-160.80	-118.62	-18.07	-13.22	-4.85
Filing Date Shares Outstanding	90	45.54	45.54	45.54	34.23	34.23
Total Common Shares Outstanding	90	45.54	45.54	45.54	34.23	34.23
Working Capital	-	657.39	754.51	579.04	56.13	1.08
Book Value Per Share	16.01	16.01	15.92	14.76	13.39	7.06
Tangible Book Value	495.4	495.4	491.61	438.65	224.75	203.22
Tangible Book Value Per Share	10.88	10.88	10.80	9.63	6.57	5.94

Data Source: S&P Global Market Intelligence Last updated: Oct 7, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 7, 2026

Data Sources Report a data error